Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP
Authors
Keywords
-
Journal
Thoracic Cancer
Volume 8, Issue 1, Pages 26-32
Publisher
Wiley
Online
2016-11-04
DOI
10.1111/1759-7714.12400
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013
- (2016) Maigeng Zhou et al. LANCET
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT
- (2015) J Yang et al. Cell Death & Disease
- ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma
- (2015) Kaori Tanaka et al. Oncotarget
- ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer
- (2014) Xiao-shan Li et al. BMC CANCER
- ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis
- (2014) Ying Liu et al. BMC CANCER
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids
- (2014) S Condello et al. ONCOGENE
- Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
- (2013) Howard A. Burris CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The PI3K/AKT pathway promotes gefitinib resistance in mutantKRASlung adenocarcinoma by a deacetylase-dependent mechanism
- (2013) Victor Jeannot et al. INTERNATIONAL JOURNAL OF CANCER
- The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
- (2013) Muhammad Alamgeer et al. THORAX
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer
- (2012) M Cortés-Sempere et al. ONCOGENE
- Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity and outcome to neoadjuvant chemotherapy
- (2011) Thaer Khoury et al. MODERN PATHOLOGY
- Aldehyde Dehydrogenase as a Marker for Stem Cells
- (2008) Jan Moreb Current Stem Cell Research & Therapy
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search